These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14981918)

  • 1. Expression of vascular endothelial growth factor and the adhesion molecule E-cadherin in non-small cell lung cancer.
    Stefanou D; Goussia AC; Arkoumani E; Agnantis NJ
    Anticancer Res; 2003; 23(6C):4715-20. PubMed ID: 14981918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
    Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H
    Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Leigh IM; Georgoulias V; Kanavaros P; Sivridis E; Gatter KC; Harris AL
    Cancer Res; 1999 Nov; 59(21):5602-7. PubMed ID: 10554041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
    Volm M; Koomägi R; Mattern J
    Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
    Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
    Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
    Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.
    Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B
    Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
    Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J
    Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.